<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec><h3>Introduction</h3>
<p>The COVID-19 pandemic that started in 2019 was a modern-world challenge for medical professionals. The SARS-Cov-2 virus targeted the respiratory and, later, the cardiovascular system. We aimed to identify the risk factors and particularities of acute myocardial infarction associated with SARS-Cov-2 infection.</p>
</sec>
<sec><h3>Material and Methods</h3>
<p>This cross-sectional study included 92 patients admitted to the Cardiology Department of Mureș County Emergency Hospital with myocardial infarction, divided into two groups: 46 patients with COVID-19 and 46 patients without COVID-19. Demographic data, risk factors, non-communicable diseases, and laboratory findings were studied and compared.</p>
</sec>
<sec><h3>Results</h3>
<p>The mean age of the patients was 65 years, and the majority were male. The identified risk factors were hypertension, body mass index >25 kg/m2, and dyslipidemia. The risk factors for poor prognosis were leukocyte count, higher neutrophil-lymphocyte ratio, higher monocyte-to-lymphocyte ratio, and higher high sensitivity troponin I levels. Left ventricular ejection fraction was significantly lower in patients with COVID-19.</p>
</sec>
<sec><h3>Conclusions</h3>
<p>COVID-19 is an aggravating factor of acute myocardial infarction. This research highlights the importance of prevention against the SARS-CoV-2 virus.</p>
</sec>
</abstract>

Introduction
The COVID-19 pandemic that started in 2019 was a modern-world challenge for medical professionals. The SARS-Cov-2 virus targeted the respiratory and, later, the cardiovascular system. We aimed to identify the risk factors and particularities of acute myocardial infarction associated with SARS-Cov-2 infection.

Material and Methods
This cross-sectional study included 92 patients admitted to the Cardiology Department of Mureș County Emergency Hospital with myocardial infarction, divided into two groups: 46 patients with COVID-19 and 46 patients without COVID-19. Demographic data, risk factors, non-communicable diseases, and laboratory findings were studied and compared.

Results
The mean age of the patients was 65 years, and the majority were male. The identified risk factors were hypertension, body mass index >25 kg/m2, and dyslipidemia. The risk factors for poor prognosis were leukocyte count, higher neutrophil-lymphocyte ratio, higher monocyte-to-lymphocyte ratio, and higher high sensitivity troponin I levels. Left ventricular ejection fraction was significantly lower in patients with COVID-19.

Conclusions
COVID-19 is an aggravating factor of acute myocardial infarction. This research highlights the importance of prevention against the SARS-CoV-2 virus.

Myocardial Infarction in the Context of COVID-19

“George Emil Palade” University of Medicine and Pharmacy, Science and Technology

Journal of Interdisciplinary Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Myocardial Infarction in the Context of COVID-19"}

Introduction
The COVID-19 pandemic that started in 2019 was a modern-world challenge for medical professionals. The SARS-Cov-2 virus targeted the respiratory...

Myocardial Infarction in the Context of COVID-19

Publicado en línea: 20 sept 2023

Páginas: 46 - 49

Recibido: 31 jul 2023

Aceptado: 03 sept 2023

DOI: https://doi.org/10.2478/jim-2023-0012

Palabras clave
myocardial infarction, COVID-19, risk factors

© 2023 Adrienn Nemeth et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Myocardial Infarction in the Context of COVID-19

Publicado en línea: 20 sept 2023

Páginas: 46 - 49

Recibido: 31 jul 2023

Aceptado: 03 sept 2023

DOI: https://doi.org/10.2478/jim-2023-0012

Palabras clavemyocardial infarction, COVID-19, risk factors

© 2023 Adrienn Nemeth et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
myocardial infarction, COVID-19, risk factors